Skip to main content

Table 1 Sociodemographic characteristics

From: Sleep architecture and cognitive changes in olanzapine-treated patients with depression: A double blind randomized placebo controlled trial

  Placebo group (N = 10) Olanzapine group (N = 15)  
N N P-value
Gender (%)     0.69
  Male 5 (50) 6 (40)  
  Female 5 (50) 9 (60)  
Diagnosis (%)     1.0
  MDD 5 (50) 7 (47)  
  BD 5 (50) 8 (53)  
Age (±SD)   46 (9) 46 (17) 0.24
Weight (±SD) Visit 1 185 (50) 178 (36) 0.76
  Visit 4 185 (51) 182 (37)  
  1. MDD = Major Depressive Disorder, BD = Bipolar Disorder. P-value reported for the test statistic for Fisher’s Exact Test (gender and diagnosis) and between groups ANOVA and repeated measures ANOVA (age and weight, respectively).